­

About admin

This author has not yet filled in any details.
So far admin has created 52 blog entries.

OncBioMune Pharmaceuticals Announces Shareholder Update

Significant Progress Continues Toward Achieving Key Milestones BATON ROUGE, LA--(October 07, 2016) - OncBioMune Pharmaceuticals Inc. (OTCQB: OBMP) ("OncBioMune" or [...]

Prostate Cancer Free for 10 Years, Stephen Karalekas Thanks OncBioMune for ProscaVax in Testimonial Video

BATON ROUGE, LA--(September 21, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Pharmaceuticals in Discussions to Acquire Vitel Laboratorios, S.A. de C.V.

Baton Rouge, Louisiana – September 14, 2016 - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a clinical stage [...]

Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer Reinforces Safety and Benefit of Novel Cancer Vaccine

BATON ROUGE, LA--(August 08, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

Pre-Clinical Research Supports Additional Studies of OncBioMune Technology for Breast Cancer Vaccine

BATON ROUGE, LA--(July 20, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Submits Protocol to Initiate Phase 2/3 Trial of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(July 13, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Research Shows Activity of PGT Technology in a Mammary Cancer Animal Model

BATON ROUGE, LA--(July 6, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Provides Corporate Update; ASCO Reinforces Market Opportunity for New Prostate Cancer Vaccine as Phase 2 Trial Approaches

BATON ROUGE, LA--(June 14, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

Mexican Regulatory Authorities Supportive of OncBioMune’s Phase 2 of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(June 02, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Pharmaceuticals to Present at the LD Micro Invitational

June 1, 2016 - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the [...]